🔎 Trials Near Me

Hjem › Ikke-småcellet lungecancer › Massachusetts › Worcester

Ikke-småcellet lungecancer kliniske forsøg i Worcester, MA

14 studier for Ikke-småcellet lungecancer søger deltagere på steder i og omkring Worcester (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RekruttererFase 3
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

RekruttererFase 3
  • University of Massachusetts Memorial Medical Center, Worcester
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06472245

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

RekruttererFase 3
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06498635

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

RekruttererFase 3
  • Reliant Medical Group, Worcester
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06890598

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

RekruttererFase 3
  • Clinical Study Site, Worcester
  • Clinical Study Site, Milford · 17 mi væk
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

RekruttererFase 2/3
  • Dana-Farber Brigham and Womens Cancer Center at Milford Regional, Milford · 17 mi væk
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT04613596

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

RekruttererFase 2
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og opefter · Alle køn · Opdateret 3. jun. 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

RekruttererFase 2
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

RekruttererFase 2
  • UMass Memorial Medical Center - University Campus, Worcester
18 Minutes · Alle køn · Opdateret 5. maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

RekruttererFase 2/3
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT06616584

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservationsstudie
  • Massive Bio SYNERGY-AI site, Worcester
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774

Ikke-småcellet lungecancer forsøg i andre byer

Andre studier i Worcester

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.